Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
17%
Ph phase_1
5
83%

Phase Distribution

5

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
5(83.3%)
Phase 2Efficacy & side effects
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Other(1)

Detailed Status

Completed3
Suspended1
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (83.3%)
Phase 21 (16.7%)

Trials by Status

suspended117%
recruiting117%
active_not_recruiting117%
completed350%

Recent Activity

2 active trials
Showing 5 of 6
active_not_recruitingphase_2

Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients

NCT04520373
recruitingphase_1

Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI

NCT05018793
suspendedphase_1

Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP

NCT05018871
completedphase_1

Adipose Stem Cells for Traumatic Spinal Cord Injury

NCT03308565
completedphase_1

Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients

NCT01257776
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04520373Phase 2

Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients

Active Not Recruiting
NCT05018793Phase 1

Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI

Recruiting
NCT05018871Phase 1

Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP

Suspended
NCT03308565Phase 1

Adipose Stem Cells for Traumatic Spinal Cord Injury

Completed
NCT01257776Phase 1

Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients

Completed
NCT01274975Phase 1

Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury.

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6